Home Neoplasma 2023 Neoplasma Vol.70, No.2, p. 179–187, 2023

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.70, No.2, p. 179–187, 2023

Title: Challenges of in situ hybridization in miRNA analysis of triple-negative breast cancer morphological diversity
Author: Markéta Kolečková, Michala Bezděková, Jan Bouchal, Mária Janíková, Júlia Bohošová, Ondřej Slabý, Marek Svoboda, Josef Srovnal, Katherine Vomáčková, Ivo Überall, Zdeněk Kolář

Abstract: miRNA expression in triple-negative breast cancers (TNBC) has mainly been studied from a methodological viewpoint. However, it has not been considered that miRNA expression profile may be associated with a specific morphological entity inside every tumor. The verification of this hypothesis on a set of 25 TNBCs was the subject of our previous work, where we confirmed specific expression of the studied miRNAs in 82 samples of different morphologies including inflammatory infiltrate, spindle cell, clear cell, and metastases after RNA extraction and purification as well as microchip and biostatistical analysis. In the current work, we demonstrate a low suitability of in situ hybridization method for miRNA detection compared to RT-qPCR, and in detail discuss the biological role of 8 miRNAs with the most significant changes of expression.

Keywords: triple-negative breast cancer (TNBC); miRNA; in situ hybridization; RT-qPCR
Published online: 22-Feb-2023
Year: 2023, Volume: 70, Issue: 2 Page From: 179, Page To: 187
doi:10.4149/neo_2023_220519N533


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.